Legionella Pneumonia in the Modern Era: Clinical Features and Predictors of Mortality
Clinical Infectious Diseases · 07.10.2026 · 83 (3) · 473-480
DOI: 10.1093/cid/ciag085 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Clinical Infectious Diseases, online erschienen am 21.02.2026. Verfasst von Aaron M Pulsipher und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care, Mayo Clinic, Phoenix, Arizona, USA. Hauptthemen laut MEDLINE: Legionnaires' Disease. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: The Mayo Clinic.
Abstract (Originalsprache)
Background
Legionella pneumonia is an important cause of severe pneumonia, yet contemporary data describing its clinical phenotype, diagnostic patterns, and outcomes in the modern era are limited.
Methods
We conducted a retrospective multicenter cohort study of adults with laboratory-confirmed Legionella pneumonia across an integrated health system between January 2019 and September 2025. The primary outcome was 30-day mortality. Severe disease was defined as having a requirement for high-flow nasal cannula, noninvasive ventilation, mechanical ventilation, or extracorporeal membrane oxygenation (ECMO). Univariate and multivariable logistic regression were used to identify predictors of mortality and severe disease.
Results
There were 344 patients with laboratory-confirmed Legionella pneumonia during the study period. The median age was 66.6 years, and 45.1% were immunocompromised. Most patients required hospital admission (94.2%), with 36.1% admitted to the intensive care unit; 22.7% required mechanical ventilation and 1.5% ECMO. Thirty- and 90-day mortality were 11.9% and 16.6%, respectively. In multivariable analysis, cirrhosis (OR 10.2, 95% CI 2.15–48.3, P = .003), immunocompromised status (odds ratio [OR] 2.24, 95% CI 1.05–4.77, P = .036), age (OR 1.03, 95% CI 1.00–1.06, P = .031), and lymphopenia at presentation (OR 2.09, 95% CI 1.02–4.24, P = .043) were independently associated with increased 30-day mortality. Among patients who were polymerase chain reaction (PCR) or culture positive, urinary antigen testing was positive in only 25.6%.
Conclusions
Legionella pneumonia was associated with substantial short-term mortality. Cirrhosis, age, immunocompromised status, and lymphopenia at presentation emerged as independent predictors of 30-day mortality, underscoring the importance of host vulnerability in determining outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Critical Care, Mayo Clinic, Phoenix, Arizona, USA.
- Department of Internal Medicine, Mayo Clinic, Phoenix, Arizona, USA.
- Division of Cardiothoracic Radiology, Mayo Clinic, Phoenix, Arizona, USA.
- Division of Clinical Microbiology, Mayo Clinic, Rochester, Minnesota, USA.
- Division of Infectious Diseases and Transplant Center, Mayo Clinic, Phoenix, Arizona, USA.
ORCID-Profile: Aaron M Pulsipher, Georges Khattar, Hunter VanDolah, Michael Gotway, Kealy Ham, Shehabaldin Alqalyoobi, Robin Patel, Patricia J Simner, Ayan Sen, Holenarasipur R Vikram
Förderung
- The Mayo Clinic
Zitieren
APA
Pulsipher, A. M., Khattar, G., VanDolah, H., Gotway, M., Ham, K., Alqalyoobi, S., Cartin-Ceba, R., Patel, R., Simner, P. J., Sen, A., & Vikram, H. R. (2026). Legionella Pneumonia in the Modern Era: Clinical Features and Predictors of Mortality. Clinical Infectious Diseases, 83(3), 473-480. https://doi.org/10.1093/cid/ciag085
Vancouver
Pulsipher AM, Khattar G, VanDolah H, Gotway M, Ham K, Alqalyoobi S, et al. Legionella Pneumonia in the Modern Era: Clinical Features and Predictors of Mortality. Clinical Infectious Diseases. 2026;83(3):473-480. doi:10.1093/cid/ciag085
BibTeX
@article{Pulsipher2026,
author = {Pulsipher, Aaron M and Khattar, Georges and VanDolah, Hunter and Gotway, Michael and Ham, Kealy and Alqalyoobi, Shehabaldin and Cartin-Ceba, Rodrigo and Patel, Robin and Simner, Patricia J and Sen, Ayan and Vikram, Holenarasipur R},
title = {Legionella Pneumonia in the Modern Era: Clinical Features and Predictors of Mortality},
journal = {Clinical Infectious Diseases},
year = {2026},
volume = {83},
number = {3},
pages = {473--480},
doi = {10.1093/cid/ciag085}
}
EUVIMED